跳至主要内容
临床试验/ACTRN12605000391673
ACTRN12605000391673已完成不适用

A randomised trial to establish the effects of early intensive blood pressure lowering on death and disability in patients with stroke due to acute intracerebral haemorrhage

The George Institute for International Health0 个研究点目标入组 400 人开始时间: 2005年9月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 ot stated(—)
性别
All

入选标准

  • Patients with CT-confirmed spontaneous Intracerebral Haemorrhage (ICH) and elevated systolic BP (>150mmHg and <220mmHg), capacity to commence randomly assigned treatment with 6 hours of onset of ICH.

排除标准

  • Clear indication for or contraindication for intensive BP lowering. Evidence ICH secondary to a structural abnormality, or use of thrombolytic agent, an ischemic stroke within 30 days, a score of 3-5 on the Galsgow Coma Scale (indicating a deep coma), significant pre-stroke disability or medical illness and planned early neurosurgical intervention.

研究者

发起方
The George Institute for International Health

相似试验